We are live on
!
Find out more
E
Ergoteles Portfolio holdings
AUM
$68.2M
1-Year Est. Return
36.16%
This Fund
S&P 500
This Quarter
Est. Return
+7.33%
1 Year Est. Return
+36.16%
3 Year Est. Return
+76.43%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.36B
AUM Growth
+$1.15B
(+36%)
Cap. Flow
+$991M
Cap. Flow
% of AUM
22.7%
Top 10 Holdings %
Top 10 Hldgs %
14.65%
Holding
1,807
New
1,048
Increased
148
Reduced
170
Closed
353
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$160M |
| 2 |
iShares Biotechnology ETF
IBB
|
+$77.5M |
| 3 |
Linde
LIN
|
+$51M |
| 4 |
State Street SPDR S&P Metals & Mining ETF
XME
|
+$46M |
| 5 |
Newmont
NEM
|
+$44.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$66.5M |
| 2 |
ExxonMobil
XOM
|
+$54.9M |
| 3 |
Apple
AAPL
|
+$52.1M |
| 4 |
HMSY
HMS Holdings Corp.
HMSY
|
+$48.4M |
| 5 |
Oracle
ORCL
|
+$42.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.39% |
| 2 | Healthcare | 14.66% |
| 3 | Consumer Discretionary | 14.56% |
| 4 | Financials | 10.08% |
| 5 | Industrials | 8.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PRAH
1
DELISTED
PRA Health Sciences, Inc.
PRAH
| $164M | 3.75% |
991,237
+957,807
| +2,865% | +$160M |
|
|
2
iShares Biotechnology ETF
IBB
$9.31B
| $99.3M | 2.28% |
606,839
+502,916
| +484% | +$77.5M |
|
3
State Street Energy Select Sector SPDR ETF
XLE
$39.5B
| $54.1M | 1.24% |
2,007,410
+1,399,010
| +230% | +$36.4M |
|
4
Berkshire Hathaway Class B
BRK.B
$1.07T
| $51.2M | 1.17% |
184,129
-112,948
| -38% | -$31.6M |
|
|
5
Linde
LIN
$237B
| $50.5M | 1.16% |
+174,841
| New | +$51M |
|
6
UnitedHealth
UNH
$382B
| $50.2M | 1.15% |
125,441
+37,760
| +43% | +$15.1M |
|
|
7
State Street SPDR S&P Metals & Mining ETF
XME
$4.05B
| $46M | 1.05% |
1,067,842
+1,058,641
| +11,506% | +$46M |
|
|
8
Newmont
NEM
$98.2B
| $42.1M | 0.97% |
+664,983
| New | +$44.6M |
|
9
Freeport-McMoran
FCX
$90B
| $41.1M | 0.94% |
1,108,831
+53,131
| +5% | +$2.07M |
|
10
Caesars Entertainment
CZR
$6.1B
| $40.9M | 0.94% |
394,068
-42,142
| -10% | -$4.25M |
|
11
Merck
MRK
$324B
| $40M | 0.92% |
+514,388
| New | +$38.3M |
|
12
Procter & Gamble
PG
$343B
| $38.9M | 0.89% |
288,421
-47,414
| -14% | -$6.42M |
|
13
Salesforce
CRM
$134B
| $35.9M | 0.82% |
+146,933
| New | +$33.9M |
|
14
Alphabet (Google) Class C
GOOG
$3.9T
| $30.6M | 0.7% |
+243,920
| New | +$29.1M |
|
15
SolarEdge
SEDG
$2.59B
| $30.3M | 0.69% |
109,500
+60,440
| +123% | +$15.2M |
|
16
PENN Entertainment
PENN
$2.74B
| $30.2M | 0.69% |
394,804
+213,846
| +118% | +$18.4M |
|
|
17
Apple
AAPL
$4.89T
| $30.1M | 0.69% |
220,097
-402,155
| -65% | -$52.1M |
|
18
Lowe's Companies
LOW
$116B
| $29.1M | 0.67% |
150,023
+14,242
| +10% | +$2.79M |
|
19
Deckers Outdoor
DECK
$13.3B
| $28.3M | 0.65% |
+442,200
| New | +$25M |
|
20
Plug Power
PLUG
$2.92B
| $27.4M | 0.63% |
800,900
+288,326
| +56% | +$8.37M |
|
21
Thermo Fisher Scientific
TMO
$211B
| $27.2M | 0.62% |
+53,918
| New | +$25.4M |
|
|
INFO
22
DELISTED
IHS Markit Ltd. Common Shares
INFO
| $26.6M | 0.61% |
236,116
+136,696
| +137% | +$14.5M |
|
23
JD.com
JD
$40.8B
| $26.4M | 0.6% |
+330,290
| New | +$24.9M |
|
24
Darling Ingredients
DAR
$9.93B
| $26.2M | 0.6% |
+387,627
| New | +$27.3M |
|
25
Lithia Motors
LAD
$7.78B
| $25.2M | 0.58% |
+73,301
| New | +$26.5M |
|
Similar funds
ROC
IVMX
AM
JCG
JAMONY
FA
VCM
MCMI
Ergoteles's Q2 2021 Portfolio in Review
As of Q2 2021, Ergoteles held 1,807 positions worth $4.36B, up 36% from $3.21B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Ergoteles deployed $991M of net new capital in Q2 2021, opening 1,048 new positions and adding to 148 existing holdings. Its largest new stake was Linde: 174,841 shares worth $50.5M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Walt Disney, an estimated $66.5M trimmed.
- Ergoteles's largest Q2 2021 buy was Linde: 174,841 shares worth $50.5M.
- Ergoteles added most to PRA Health Sciences, Inc. in Q2 2021, an estimated $160M increase.
- Ergoteles's biggest Q2 2021 reduction was Walt Disney, cutting an estimated $66.5M.
- Ergoteles fully exited ExxonMobil in Q2 2021, selling an estimated $54.9M.
- Ergoteles's ten largest holdings make up 15% of its $4.36B portfolio in Q2 2021.
- Ergoteles opened 1,048 new positions and closed 353 in Q2 2021.
- Ergoteles's portfolio value rose 36% quarter-over-quarter to $4.36B.
Based on Ergoteles's 13F filing for Q2 2021, filed 12 Aug 2021.